Drug discovery startup Recursion raises $60 million in Series B from Data Collective 

 Recursion, a drug discovery startup out of Salt Lake City, Utah has announced a $60 million Series B round, led by Data Collective (DCVC). Recursion started out in 2014 on a mission to identify 100 new treatments in 10 years. That’s a lofty goal, considering the discovery for just one drug can traditionally take decades and tens of millions of dollars, with a high rate of failure… Read More

Smart tattoos turn your skin into a health tracker

There's a common problem with health-tracking devices like smartwatches: they're not really attached to you, which leaves you relying on a short-lived battery and a wireless connection. Even a self-powered patch has its limits. That's where Harvard…

The FDA has approved a blood sugar monitor that doesn’t require a finger prick

 Further proof the U.S. Food and Drug Administration has been warming up to modern technology — it has just approved the first continuous blood sugar monitor that doesn’t require the user to prick themselves over and over for a blood sample. Today, the FDA cleared Abbot’s FreeStyle Libre Flash Glucose Monitoring System, a device that uses a small sensor wire inserted under… Read More

Facebook helps blood donation go viral

 Facebook doesn’t just want to make it easy to sign up to be a blood donor from the News Feed. It’s also creating a special kind of post for requesting blood donations of a certain type in a certain location, and then notifying nearby donors that qualify. While many people are interested and willing to give blood, they might not know how to sign up, where to go, or have the… Read More

Roivant receives bad news — and so does SoftBank

 Last month, SoftBank, through its massive Vision Fund, led the single biggest private financing round for a healthcare company ever — funneling $1.1 billion into the drug holding outfit Roivant Sciences. Today, the Japanese conglomerate might be regretting that decision. Read More

Apple, Alphabet and Fitbit test FDA fast track for health apps

A few of the tech giants you know are about to get fast-track approval for their digital health efforts. The US Food and Drug Administration has named the companies involved in a recently-instituted "pre-certification" program that determines whethe…

Maze-like chip helps spot aggressive cancer cells

It's difficult to spot cancer cells — just one in a billion blood cells are cancerous. How do you isolate them to know the trouble someone is facing and eventually treat it? By drawing the kind of mazes you enjoyed as a kid, apparently. Researche…

Don’t wait for the Apple Watch to dole out medical advice anytime soon

 Could the Food and Drug Administration classify the Apple Watch as a medical device? It’s a question many have asked over the past couple of years, but the stakes are now higher for the Watch with its newfound ability to detect atrial fibrillation, or an irregular heart rhythm. Already, Apple is rumored to be working on an Apple Watch sensor that would detect and monitor glucose… Read More